Letter to the Editor
Experience with subcutaneous levetiracetam in palliative care patients: prognostic and pharmacological considerations
Experiencia de uso de levetiracetam subcutáneo en pacientes paliativos: consideración pronóstica y farmacológica
Read
2558
Timeswas read the article
314
Total PDF
2244
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 22 | 3 | 25 |
| 2025 11 | 306 | 26 | 332 |
| 2025 10 | 213 | 10 | 223 |
| 2025 9 | 164 | 18 | 182 |
| 2025 8 | 178 | 18 | 196 |
| 2025 7 | 194 | 9 | 203 |
| 2025 6 | 117 | 2 | 119 |
| 2025 5 | 61 | 3 | 64 |
| 2025 4 | 59 | 4 | 63 |
| 2025 3 | 54 | 2 | 56 |
| 2025 2 | 95 | 5 | 100 |
| 2025 1 | 122 | 18 | 140 |
| 2024 12 | 29 | 2 | 31 |
| 2024 11 | 33 | 2 | 35 |
| 2024 10 | 20 | 0 | 20 |
| 2024 9 | 18 | 2 | 20 |
| 2024 8 | 19 | 6 | 25 |
| 2024 7 | 19 | 6 | 25 |
| 2024 6 | 30 | 0 | 30 |
| 2024 5 | 24 | 4 | 28 |
| 2024 4 | 33 | 8 | 41 |
| 2024 3 | 23 | 3 | 26 |
| 2024 2 | 20 | 3 | 23 |
| 2024 1 | 26 | 4 | 30 |
| 2023 12 | 12 | 8 | 20 |
| 2023 11 | 17 | 5 | 22 |
| 2023 10 | 24 | 14 | 38 |
| 2023 9 | 19 | 7 | 26 |
| 2023 8 | 16 | 6 | 22 |
| 2023 7 | 18 | 5 | 23 |
| 2023 6 | 24 | 8 | 32 |
| 2023 5 | 52 | 5 | 57 |
| 2023 4 | 41 | 4 | 45 |
| 2023 3 | 20 | 6 | 26 |
| 2023 2 | 16 | 7 | 23 |
| 2023 1 | 11 | 12 | 23 |
| 2022 12 | 8 | 8 | 16 |
| 2022 11 | 19 | 4 | 23 |
| 2022 10 | 9 | 5 | 14 |
| 2022 9 | 8 | 11 | 19 |
| 2022 8 | 22 | 12 | 34 |
| 2022 7 | 17 | 8 | 25 |
| 2022 6 | 9 | 7 | 16 |
| 2022 5 | 3 | 14 | 17 |
Show all
